Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among ...

Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...

This research aims to create dabrafenib (DBF)-loaded nanosponges (NSPs) using β-cyclodextrin (β-CD) and diphenyl carbonate (DPC) as linker to improve oral bioavailability. DBF-loaded β-CD NSPs were ...

In July last year, after the Lok Sabha elections, the Health Ministry was allocated Rs 90958.63 crore in the Union Budget 2024-25.

During 2024, the radiopharmaceutical Pluvicto achieved blockbuster status, while sales of the breast cancer drug Kisqali grew 46 percent compared to 2023.

Dr. Blackman co-founded Day One Biopharmaceuticals in 2018 with a vision to identify, acquire, and develop promising new treatments to address childhood cancers. Under Dr. Blackman’s leadership, Day ...

Nationwide analysis of Medicare expenditure and utilization of EGFR inhibitors from 2018-2022. Genetic variants and clinical factors affecting the response to 5-fluorouracil–based treatment in Chilean ...